In glioma cell lines (i.e., U87-MG, U251, ln18, and U373), UBE2C, a known glioma tumor progression protein, harbors two FOXM1 binding sites on its promoter, strongly suggesting that it could be another direct transcriptional target of FOXM1. The gene discussed is UBE2C; the disease is central nervous system cancer.